ZenaTech Sets 2027 Adjusted EBITDA Breakeven Target Amid 425% H1 Revenue Growth, but Cash Burn Concerns Remain

What happened

ZenaTech announced on October 26, 2026, that management is targeting adjusted EBITDA breakeven in 2027, citing 425% first-half revenue growth and anticipated operating efficiencies. The company continues to expand its Drone-as-a-Service operations, but the latest DeepValue report highlighted that revenue growth has not yet translated into positive cash flow, with free cash flow of -$8.36M in Q3 2025 and negative tangible equity. The breakeven target is two years away, and achieving it will require substantial improvement in unit economics and cost control, which have yet to be demonstrated. The analyst's prior stance was 'Potential Sell' with a conviction of 4 out of 5, based on dilution risk and unproven DaaS profitability. While the new revenue growth data is encouraging, it does not materially change the near-term risk profile, as the company remains reliant on external financing to fund its aggressive expansion.

Implication

The 425% H1 revenue growth confirms continued demand for ZenaTech's DaaS model, but it does not address the core issue of deeply negative free cash flow and growing losses. The 2027 breakeven target is two years away and depends on achieving significant operating leverage that has been absent so far. The company will likely need to raise additional capital before reaching breakeven, which could dilute existing shareholders substantially. The DeepValue report's 'Potential Sell' rating remains appropriate, with an attractive entry point near $2.50 and a trim level above $6.00. Investors should monitor quarterly cash burn trends and any evidence of margin improvement in subsequent reports before considering a more constructive stance.

Thesis delta

The news provides a concrete, though distant, profitability target (2027 adjusted EBITDA breakeven) and confirms continued hypergrowth, which modestly strengthens the long-term narrative. However, it does not address near-term cash burn, negative tangible equity, or reliance on external funding, which remain central risks. The overall thesis of potential overvaluation and dilution risk is unchanged, and the 'Potential Sell' rating stands.